The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-19-1086
PubMed Identifier: 32430479
Publication URI: http://europepmc.org/abstract/MED/32430479
Type: Journal Article/Review
Volume: 26
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 16
ISSN: 1078-0432